When tested in a co-culture system of T47D breast cancer cells with human breast adipose fibroblasts (BAFs), resveratrol (20 μM) promoted an aromatase inhibitory effect as potent as 20 nM of letrozole, which is a clinically used anti-aromatase drug in breast cancer treatment [176]. This evidence concerns the gene CYP19A1 and breast carcinoma.